Johan Vessby

8PUBLICATIONS
36CO-AUTHORS
Metabolic medicineMedical infection agents (incl. prions)Cardiology (incl. cardiovascular diseases)Medical biochemistry - proteins and peptides (incl. medical proteomics)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Comorbid type 2 diabetes and cardiovascular disease drive higher healthcare costs in MASLD/MASH: a retrospective Swedish cohort study.

|Feb 06, 2026
Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD.

Sofia Ullman, Hannes Hegmar, Johan Vessby

|Apr 16, 2025
Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study.

Magnus Holmer, Michael Ingre, Martti Färkkilä

|Apr 16, 2025
Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study.

Julia Blomdahl, Mikael Åberg, Michael Fridén

|Apr 01, 2022
AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis.

Johan Vessby, Jacek R Wisniewski, Cecilia Lindskog

|Oct 19, 2021
Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.

Sofi Sennefelt Nyman, Angeliki Dimopoulou Creusen, Ulf Johnsson

Pageof 2

Frequent Collaborators

3 joint publications

Mattias Ekstedt

3 joint publications

Stergios Kechagias

2 joint publications

Mikael Åberg

2 joint publications

Fredrik Rorsman